Novartis to provide 'no profit' COVID-19 drugs to low income countries

Novartis’s Sandoz division (NOVN.S) will not profit from 15 generic drugs it is making available to developing countries to treat symptoms of COVID-19 for the pandemic’s duration, the Swiss drugmaker said on Thursday.